Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1996 1
2000 1
2008 1
2009 1
2011 1
2014 1
2015 1
2018 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Mechanism(s) of the blood glucose lowering action of benfluorex.
Riccio A, Vigili de Kreutzenberg S, Dorella M, Da Tos V, De Biasi L, Marescotti MC, Tiengo A, Del Prato S. Riccio A, et al. Among authors: da tos v. Diabetes Metab Rev. 1993 Nov;9 Suppl 1:19S-27S. doi: 10.1002/dmr.5610090505. Diabetes Metab Rev. 1993. PMID: 8299485 Clinical Trial.
Mechanisms of acute and chronic hypoglycemic action of gliclazide.
da Tos V, Maran A, Vigili de Kreutzenberg S, Marchetto S, Tadiotto F, Bettio M, Marescotti MC, Tiengo A, Del Prato S. da Tos V, et al. Acta Diabetol. 2000;37(4):201-6. doi: 10.1007/s005920070006. Acta Diabetol. 2000. PMID: 11450504 Clinical Trial.
[Mechanisms of hypoglycemic action of benfluorex].
Vigili de Kreutzenberg S, Riccio A, Dorella M, Da Tos V, Del Prato S. Vigili de Kreutzenberg S, et al. Among authors: da tos v. Presse Med. 1992 Sep 9;21(28):1340-3. Presse Med. 1992. PMID: 1438104 Clinical Trial. French.
Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
Lapolla A, Frison V, Bettio M, Dal Pos M, Rocchini P, Panebianco G, Tadiotto F, Da Tos V, D'Ambrosio M, Marangoni A, Ferrari M, Pianta A, Balzano S, Confortin L, Lamonica M, Marin N, Strazzabosco M, Brun E, Mesturino CA, Simoncini M, Zen F, Bax G, Bonsembiante B, Cardone C, Dal Frà MG, Gallo A, Masin M, Piarulli F, Sartore G, Simioni N. Lapolla A, et al. Among authors: da tos v. Clin Ther. 2015 Mar 1;37(3):574-84. doi: 10.1016/j.clinthera.2014.11.015. Epub 2015 Jan 24. Clin Ther. 2015. PMID: 25626486
Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
Dorella M, Giusto M, Da Tos V, Campagnolo M, Palatini P, Rossi G, Ceolotto G, Felice M, Semplicini A, Del Prato S. Dorella M, et al. Among authors: da tos v. J Clin Endocrinol Metab. 1996 Apr;81(4):1568-74. doi: 10.1210/jcem.81.4.8636369. J Clin Endocrinol Metab. 1996. PMID: 8636369 Clinical Trial.